{"entity":{"type":"insider","cik":"0001478733","url":"/insider/0001478733","json_url":"/insider/0001478733.json","name":"Damaj Bassam","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":5,"first":"2012-08-21","last":"2013-06-14","span_basis":"filed_date"},"name_variants":[{"name":"Damaj Bassam","source":"filing","n_filings":5,"first_seen":"2012-08-21","last_seen":"2013-06-14"}],"transactions":[{"id":5204563,"accession":"0001181431-13-035106","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-13-035106","line_url":"/filing/0001181431-13-035106","is_derivative":false,"issuer_cik":"0001411879","issuer_name":"INNOVUS PHARMACEUTICALS, INC.","issuer_ticker":"INNV","issuer_name_source":null,"issuer_url":"/issuer/0001411879","owner_cik":"0001478733","owner_name":"Damaj Bassam","owner_display_name":"Damaj Bassam","owner_url":"/insider/0001478733","role":"Director, Officer (President & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":416841.0,"shares_display":"416,841","price_per_share":0.323,"price_display":"0.32","price_state":"stated","total_value":134639.643,"total_display":"134,639.64","total_whole":"134,640","shares_owned_after":5051270.0,"shares_owned_after_display":"5,051,270","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-12","filed_date":"2013-06-14","scope":"insider","n_lines":2},{"id":9236346,"accession":"0001144204-13-008393","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-13-008393","line_url":"/filing/0001144204-13-008393#line-1","is_derivative":false,"issuer_cik":"0001411879","issuer_name":"INNOVUS PHARMACEUTICALS, INC.","issuer_ticker":"INNV","issuer_name_source":null,"issuer_url":"/issuer/0001411879","owner_cik":"0001478733","owner_name":"Damaj Bassam","owner_display_name":"Damaj Bassam","owner_url":"/insider/0001478733","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250406.0,"shares_display":"250,406","price_per_share":0.4752,"price_display":"0.48","price_state":"stated","total_value":118992.9312,"total_display":"118,992.93","total_whole":"118,993","shares_owned_after":3459877.0,"shares_owned_after_display":"3,459,877","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-02-02","filed_date":"2013-02-13","scope":"insider"},{"id":5253706,"accession":"0001144204-13-006185","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-13-006185","line_url":"/filing/0001144204-13-006185#line-1","is_derivative":false,"issuer_cik":"0001411879","issuer_name":"INNOVUS PHARMACEUTICALS, INC.","issuer_ticker":"INNV","issuer_name_source":null,"issuer_url":"/issuer/0001411879","owner_cik":"0001478733","owner_name":"Damaj Bassam","owner_display_name":"Damaj Bassam","owner_url":"/insider/0001478733","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250406.0,"shares_display":"250,406","price_per_share":0.4752,"price_display":"0.48","price_state":"stated","total_value":118992.9312,"total_display":"118,992.93","total_whole":"118,993","shares_owned_after":250406.0,"shares_owned_after_display":"250,406","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-02-02","filed_date":"2013-02-05","scope":"insider"},{"id":3410383,"accession":"0001144204-12-047886","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-12-047886","line_url":"/filing/0001144204-12-047886#line-1","is_derivative":false,"issuer_cik":"0001017491","issuer_name":"APRICUS BIOSCIENCES, INC.","issuer_ticker":"APRI","issuer_name_source":null,"issuer_url":"/issuer/0001017491","owner_cik":"0001478733","owner_name":"Damaj Bassam","owner_display_name":"Damaj Bassam","owner_url":"/insider/0001478733","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":760.0,"shares_display":"760","price_per_share":2.77,"price_display":"2.77","price_state":"stated","total_value":2105.2,"total_display":"2,105.20","total_whole":"2,105","shares_owned_after":1611747.0,"shares_owned_after_display":"1,611,747","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-08-21","filed_date":"2012-08-23","scope":"insider"},{"id":3327641,"accession":"0001144204-12-047248","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-12-047248","line_url":"/filing/0001144204-12-047248#line-1","is_derivative":false,"issuer_cik":"0001017491","issuer_name":"APRICUS BIOSCIENCES, INC.","issuer_ticker":"APRI","issuer_name_source":null,"issuer_url":"/issuer/0001017491","owner_cik":"0001478733","owner_name":"Damaj Bassam","owner_display_name":"Damaj Bassam","owner_url":"/insider/0001478733","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500.0,"shares_display":"1,500","price_per_share":2.6895,"price_display":"2.69","price_state":"stated","total_value":4034.25,"total_display":"4,034.25","total_whole":"4,034","shares_owned_after":1361985.0,"shares_owned_after_display":"1,361,985","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-08-20","filed_date":"2012-08-21","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001411879","name":"INNOVUS PHARMACEUTICALS, INC.","url":"/issuer/0001411879","role":"Director, Officer (President & CEO), Ten percent owner","n_filings":3,"first_seen":"2013-02-05","last_seen":"2013-06-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001017491","name":"APRICUS BIOSCIENCES, INC.","url":"/issuer/0001017491","role":"Director, Officer (President and CEO)","n_filings":2,"first_seen":"2012-08-21","last_seen":"2012-08-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001478733","retrieved_at":"2026-08-26T06:35:34+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}